Ownership history in RENAISSANCE TECHNOLOGIES LLC · 6 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in SAB BIOTHERAPEUTICS INC (SABS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 80,840 | +69,810 | +632.9% | 0.00% | $162K | $2.01 |
| 2025 Q2 | ADDED | 11,030 | +1,000 | +10.0% | 0.00% | $19K | $1.75 |
| 2025 Q1 | REDUCED | 10,030 | -53,070 | -84.1% | 0.00% | $14K | $1.36 |
| 2023 Q4 | ADDED | 63,100 | +5,000 | +8.6% | 0.00% | $43K | $6.88 |
| 2023 Q3 | ADDED | 58,100 | +3,700 | +6.8% | 0.00% | $37K | $6.30 |
| 2023 Q2 | INITIATED | 54,400 | — | — | 0.00% | $45K | $8.30 |
As of 2025 Q4 — sorted by position size